An unproven stem cell therapy conducted by a Florida clinic has blinded three patients in an manifest clinical trial gone horribly wrong . The incident showcases the extent to which unscrupulous clinics will take vantage of desperate patients — and how the want of administration supervision bring to the problem .
As reported in the New England Journal of Medicine , the clinical trial — if it can be telephone that — demand three women between the eld of 72 and 88 who were suffer from macular degeneration , a rough-cut progressive disease of the retina that leads to deprivation of visual sensation . The women , all of whom were experiencing various degrees of vision loss , seek the help of a Florida clinic , which claimed to be testing a stem cubicle procedure designed to treat macular decadence . Sometime in 2015 , a week after stem cell were injected into their eyes , the women became blind . Two years by and by , doctors say there ’s virtually no chance the woman ’s vision will be mend .
The authors of the Modern report , ophthalmologists Jeffrey Goldberg from Stanford University School of Medicine and Thomas Albini from the University of Miami , say the unfortunate incident serve as “ a call to cognisance for patient , physicians and regulative agencies of the risks of this kind of minimally regulated , patient - funded inquiry . ”
stalk cells are uniform cell that have n’t quite decided what they require to be when they grow up . Under the right conditions , these young cell can be transform into almost any sort of cell found in the soundbox , which is why they ’ve proven useful in regenerative music .
finally , scientist hope to be able to expend stem cells to regenerate damaged tissue and electronic organ — and possibly even renovate the effects of macular degeneration — but we ’re not there yet . The only truly in effect clinical lotion of stem cell to date has been inbone core transplants , in which root word electric cell extract from a presenter ’s os marrow are used to produce a fresh blood system for patients suffer from blood disorders such as cancer of the blood . Arecent studyshowed that there are near 600 clinic peddling unproven stem - cell procedures in the United States for a wide range of condition , include arthritis , autism , cerebral palsy , stroking , muscular dystrophy , and genus Cancer .
As noted in the NEJM report , two of the three patients learned about the stem turn cell trial for macular degeneration onClinicalTrials.gov , a registry hightail it by the US National Library of Medicine . The listings on this site are n’t fully scrutinized for scientific efficacy . The patient were reportedly under the Assumption of Mary that they were participating in a bonafide clinical trial , but the consent shape and other materials made no mention of a tryout . Tellingly , each patient had to pay $ 5,000 for the procedure . This is extremely maverick for a clinical run , and it should have been cause for alarm . “ I ’m not aware of any lawful research , at least in ophthalmology , that is patient - fund , ” Albini said in a financial statement .
The NEJM study did n’t identify the Florida clinic responsible , but ( handily ) the authors provided the name of the test : “ Study to assess the guard and issue of cellular phone inject intravitreal in dry macular . ” A quick Google searchcalls the test up , along with the name of the company responsible : Bioheart Inc. , otherwise known asUS Stem Cell . As the ClinicalTrials.gov page indicates , the study “ has been withdrawn prior to enrollment . ” According to Goldberg and Albini , the company is no longer performing the function , but it is still experience patients .
The trial itself was a joke , lacking in all the components of a properly designed test . It was n’t based on prior laboratory experimentation , no control group was put , no data was collect , and no architectural plan were made for follow - ups .
During the function , the affected role had some of their fatty cells ( i.e. adipose tissue ) removed , along with a standard rake withdrawal . The fat tissue were then processed with an enzyme to draw out stem cells . Once plasma was isolate from the rakehell and add to the stem cells , the mixing was shoot into both eyes of each patient — yes , both eye . Again , another serious clinical no - no ; normally , only one eye would be injected for an observational procedure like this in the event that something should go wrong . The entire procedure last less than an hour .
A calendar week later , all three cleaning lady were blind . As observe in the NEJM account , the cecity was accompany by detached retina and hemorrhaging .
The patients ’ severe ocular loss after the injection was link with ocular hypertension , hemorrhagic retinopathy , vitreous hemorrhage , combined grip and rhegmatogenous retinal insularity , and genus Lens dislocation . After one yr , the patients ’ visual acuity stray from 20/200 to no light perception .
Goldberg and Albini say the preparation of the stem turn cells was likely shoddy , and the injectant may have been contaminate . Once in the eye , the fore cells could have changed into myofibroblasts , a type of cell associated with scarring .
The Florida clinic , it would seem , was appealing to the desperation of their patients , while taking reward of a regulative loophole . As the authors indite in their report :
Adipose tissue paper – derived “ stem cell ” have been more and more used by “ stem - cell clinics ” because of the proportional ease of obtaining and preparing these jail cell . Many of the clinics that bring home the bacon these root - cell therapy have done so under the aegis of affected role - funded , institutional recap table – approve research , and the research is listed on ClinicalTrials.gov without an investigational new drug filing with the FDA .
At the time , the procedure was not open to FDA favorable reception because the cells were n’t transferred between affected role , and because the cells were conceive “ minimally processed . ” The FDAhas since retool its necessity , and it now need approval for these case of procedures . In summation to update its regularization , the FDA is also clamping down on stem jail cell clinic .
https://gizmodo.com/why-trumps-latest-attack-on-the-fda-was-total-nonsense-1792862548
That ’s obviously a dependable thing , but it ’s a little too late for the adult female involved . This incident shows what happens when regulations and supervising are weak , and how shadowed companies will take risk with their affected role ’ wellness . for sure food for thoughtas Trump and his crony start to recreate the FDA in their own simulacrum .
Update : We reached out to US Stem Cell Clinic for comment and they respond with this statement :
establish in 1999 , U.S Stem Cell , Inc. has been committed to the research and development of effective cellphone technologies to treat affected role with a variety of disease and injuries . Since 2001 , our clinics have successfully deport more than 7,000 stem jail cell procedures with less than 0.01 % adverse reaction describe . We are unable to comment further on specific fount due to patient confidentiality or legal confidentiality obligations . Neither US Stem Cell nor US Stem Cell Clinic currently cover optic patients .
[ New England Journal of Medicine ]
BiologyBlindnessMedicineSciencescience scandals
Daily Newsletter
Get the best tech , skill , and finish news in your inbox day by day .
News from the future tense , delivered to your present .
You May Also Like
